Volume 6, issue 1, December 2005
18 articles in this issue
-
-
Compliance of a cobalt chromium coronary stent alloy – the COVIS trial
Authors (first, second and last of 4)
-
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
Authors (first, second and last of 5)
-
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Authors (first, second and last of 5)
-
Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm
Authors (first, second and last of 6)
-
-
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction
Authors (first, second and last of 7)
-
The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]
Authors (first, second and last of 6)
-
Exercise training improves aerobic endurance and musculoskeletal fitness in female cardiac transplant recipients
Authors (first, second and last of 7)
-
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
Authors (first, second and last of 8)
-
Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]
Authors (first, second and last of 9)
-
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation
Authors (first, second and last of 7)
-
-
-
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
Authors (first, second and last of 17)
-
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
Authors (first, second and last of 6)
-
Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma
Authors (first, second and last of 7)
-
